1. OP0095 Randomized, Placebo-Controlled Trial To Evaluate Clinical Efficacy and Structure Modifying Properties of Subcutaneous Etanercept (ETN) in Patients with Erosive Inflammatory Hand Osteoarthritis (OA). (15th July 2016) Authors: Kloppenburg, M.; Ramonda, R.; Kwok, W.-Y.; Bobacz, K.; Elewaut, D.; Frallonardo, P.; Huizinga, T.W.; Kroon, F.; Smolen, J.; Vander Cruyssen, B.; Wolterbeek, R.; Punzi, L.; Verbruggen, G.; Wittoek, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0180 Remission Induction with Dmard Combinations and Glucocorticoids is not Superior to Remission Induction with MTX Monotherapy and Glucocorticoids: Week 52 Results of the High-Risk Group from the Carera Trial. (9th June 2015) Authors: Verschueren, P.; De Cock, D.; Corluy, L.; Joos, R.; Langenaken, C.; Taelman, V.; Raeman, F.; Ravilingien, I.; Vandevyvere, K.; Lenaerts, J.; Geens, E.; Geusens, P.; Vanhoof, J.; Durnez, A.; Remans, J.; Vander Cruyssen, B.; Van Essche, E.; Sileghem, A.; De Brabanter, G.; Joly, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomised, placebo-controlled trial to evaluate clinical efficacy and structure modifying properties of subcutaneous etanercept in patients with erosive inflammatory hand osteoarthritis. (April 2017) Authors: Kloppenburg, M.; Ramonda, R.; Kwok, W.-Y.; Bobacz, K.; Elewaut, D.; Frallonardo, P.; Huizinga, T.W.; Kroon, F.P.; Smolen, J.; Vander Cruyssen, B.; Wolterbeek, R.; Punzi, L.; Verbruggen, G.; Wittoek, R. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0117 Low-Risk Patients Also Benefit from Remission Induction Treatment in Early Rheumatoid Arthritis: Week 52 Results from the Carera Trial. (9th June 2015) Authors: De Cock, D.; Corluy, L.; Joos, R.; Langenaken, C.; Taelman, V.; Raeman, F.; Ravilingien, I.; Vandevyvere, K.; Lenaerts, J.; Geens, E.; Geusens, P.; Vanhoof, J.; Durnez, A.; Remans, J.; Vander Cruyssen, B.; Van Essche, E.; Sileghem, A.; De Brabanter, G.; Joly, J.; Meyfroidt, S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0121 Comparison of MTX Therapy with or without A Moderate Dose Glucocorticoid Bridging Scheme in Early Rheumatoid Arthritis Patients Lacking Classical Poor Prognostic Markers: Week 16 Results from the Randomized Multicenter Carera Trial. (10th June 2014) Authors: De Cock, D.; Westhovens, R.; Corluy, L.; Joos, R.; Langenaken, C.; Taelman, V.; Raeman, F.; Ravelingien, I.; Vandevyvere, K.; Lenaerts, J.; Geens, E.; Geusens, P.; Vanhoof, J.; Durnez, A.; Remans, J.; Vander Cruyssen, B.; Van Essche, E.; Sileghem, A.; De Brabanter, G.; Joly, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0137 Associated with A Glucocorticoid Bridging Scheme, Methotrexate is as Effective Alone as in Combination with Other DMARDS for Early Rheumatoid Arthritis, with Fewer Reported Side Effects: 16 Weeks Remission Induction Data from the Carera Trial. (10th June 2014) Authors: Verschueren, P.; De Cock, D.; Corluy, L.; Joos, R.; Langenaken, C.; Taelman, V.; Raeman, F.; Ravelingien, I.; Vandevyvere, K.; Lenaerts, J.; Geens, E.; Geusens, P.; Vanhoof, J.; Durnez, A.; Remans, J.; Vander Cruyssen, B.; Van Essche, E.; Sileghem, A.; De Brabanter, G.; Joly, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗